Literature DB >> 8271043

Technetium-99m pertechnetate salivary gland imaging: its role in the diagnosis of Warthin's tumor.

G S Weinstein1, R T Harvey, W Zimmer, S Ter, A Alavi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8271043

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  6 in total

1.  Tl-201 uptake and retention in a Warthin's tumor.

Authors:  A S Arbab; K Koizumi; T Arai; K Toyama; T Araki
Journal:  Ann Nucl Med       Date:  1996-08       Impact factor: 2.668

2.  Retrospective review: usefulness of a number of imaging modalities including CT, MRI, technetium-99m pertechnetate scintigraphy, gallium-67 scintigraphy and F-18-FDG PET in the differentiation of benign from malignant parotid masses.

Authors:  Nozomi Ozawa; Terue Okamura; Koichi Koyama; Keiko Nakayama; Joji Kawabe; Susumu Shiomi; Hideo Yamane; Yuichi Inoue
Journal:  Radiat Med       Date:  2006-01

3.  Changing frequency of parotid gland neoplasms--analysis of 560 tumours treated in a district general hospital.

Authors:  M Ethunandan; C A Pratt; D W Macpherson
Journal:  Ann R Coll Surg Engl       Date:  2002-01       Impact factor: 1.891

4.  Modulation of sodium/iodide symporter expression in the salivary gland.

Authors:  Krista M D La Perle; Dong Chul Kim; Nathan C Hall; Adam Bobbey; Daniel H Shen; Rebecca S Nagy; Paul E Wakely; Amy Lehman; David Jarjoura; Sissy M Jhiang
Journal:  Thyroid       Date:  2013-07-17       Impact factor: 6.568

5.  Preoperative Diagnostic Strategy for Parotid Gland Tumors Using Diffusion-Weighted MRI and Technetium-99m Pertechnetate Scintigraphy: A Prospective Study.

Authors:  Masahiro Kikuchi; Sho Koyasu; Shogo Shinohara; Yukihiro Imai; Megumu Hino; Yasushi Naito
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

6.  Multifocal Warthin's Tumor: An Uncommon Presentation of Bilateral Cervical Lymphadenopathy.

Authors:  Ryan A Rimmer; Elizabeth E Cottrill
Journal:  Case Rep Otolaryngol       Date:  2018-09-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.